JP2020527149A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527149A5 JP2020527149A5 JP2020502295A JP2020502295A JP2020527149A5 JP 2020527149 A5 JP2020527149 A5 JP 2020527149A5 JP 2020502295 A JP2020502295 A JP 2020502295A JP 2020502295 A JP2020502295 A JP 2020502295A JP 2020527149 A5 JP2020527149 A5 JP 2020527149A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- och
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 51
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- -1 substituted Chemical class 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 6
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 4
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims description 4
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 2
- CIISBYKBBMFLEZ-UHFFFAOYSA-N 1,2-oxazolidine Chemical compound C1CNOC1 CIISBYKBBMFLEZ-UHFFFAOYSA-N 0.000 claims description 2
- VIGBFZWIHCQBKB-UHFFFAOYSA-N 1,2-thiazole-4,5-dione Chemical compound O=C1SN=CC1=O VIGBFZWIHCQBKB-UHFFFAOYSA-N 0.000 claims description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 claims description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 2
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 claims description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 2
- 229940123464 Thiazolidinedione Drugs 0.000 claims description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- UMVKIYNXBSNJJZ-UHFFFAOYSA-N imidazolidin-2-one imidazolidin-4-one Chemical compound N1CNC(C1)=O.N1C(NCC1)=O UMVKIYNXBSNJJZ-UHFFFAOYSA-N 0.000 claims description 2
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 claims description 2
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 claims description 2
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 claims description 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 2
- 150000003536 tetrazoles Chemical class 0.000 claims description 2
- 150000003852 triazoles Chemical class 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 150000001467 thiazolidinediones Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 1
- MDTUWBLTRPRXBX-UHFFFAOYSA-N 1,2,4-triazol-3-one Chemical compound O=C1N=CN=N1 MDTUWBLTRPRXBX-UHFFFAOYSA-N 0.000 description 1
- XBYRMPXUBGMOJC-UHFFFAOYSA-N 1,2-dihydropyrazol-3-one Chemical compound OC=1C=CNN=1 XBYRMPXUBGMOJC-UHFFFAOYSA-N 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
- ZRHUHDUEXWHZMA-UHFFFAOYSA-N 1,4-dihydropyrazol-5-one Chemical compound O=C1CC=NN1 ZRHUHDUEXWHZMA-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- OYODOQNYJLSLJE-UHFFFAOYSA-N pyrazol-4-one Chemical compound O=C1C=NN=C1 OYODOQNYJLSLJE-UHFFFAOYSA-N 0.000 description 1
- FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical compound O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102017212264 | 2017-07-18 | ||
| DE102017212264.1 | 2017-07-18 | ||
| PCT/EP2017/084120 WO2019015794A1 (en) | 2017-07-18 | 2017-12-21 | NEW ALBICIDINE DERIVATIVES, THEIR USE AND THEIR SYNTHESIS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527149A JP2020527149A (ja) | 2020-09-03 |
| JP2020527149A5 true JP2020527149A5 (https=) | 2021-01-28 |
| JP7257697B2 JP7257697B2 (ja) | 2023-04-14 |
Family
ID=60972211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502295A Active JP7257697B2 (ja) | 2017-07-18 | 2017-12-21 | 新規アルビシジン誘導体、それらの使用および合成 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11225465B2 (https=) |
| EP (1) | EP3655394B1 (https=) |
| JP (1) | JP7257697B2 (https=) |
| CN (1) | CN110997641A (https=) |
| CA (1) | CA3070240A1 (https=) |
| WO (1) | WO2019015794A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3974416A1 (en) * | 2020-09-23 | 2022-03-30 | Technische Universität Berlin | Novel albicidin derivatives, their use and synthesis |
| EP4286373A1 (en) * | 2022-05-30 | 2023-12-06 | Technische Universität Berlin | Novel albicidin derivatives, their use and synthesis |
| WO2024102890A2 (en) * | 2022-11-11 | 2024-05-16 | The Board Of Regents Of The University Of Texas System | Amino acid-benzoic acid oligomers and methods of use thereof for treating cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4525354A (en) | 1983-09-14 | 1985-06-25 | University Of Hawaii | Antibiotic and process for the production thereof |
| EP2956437B1 (en) | 2013-02-15 | 2023-05-10 | Technische Universität Berlin | Albicidin derivatives for the treatment of bacterial infections |
| JP6730183B2 (ja) * | 2013-07-12 | 2020-07-29 | ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー | シストバクトアミド（Ｃｙｓｔｏｂａｃｔａｍｉｄｅｓ） |
| US20170204052A1 (en) | 2014-05-15 | 2017-07-20 | Korea Research Institute Of Bioscience And Biotechnology | Novel antimicrobial compound and use thereof |
| CA2968270C (en) | 2014-11-26 | 2022-11-01 | Helmholtz-Zentrum Fur Infektionsforschung Gmbh | Further natural cystobactamides, synthetic derivatives thereof, and use thereof in treating bacterial infections |
-
2017
- 2017-12-21 EP EP17829200.9A patent/EP3655394B1/en active Active
- 2017-12-21 CN CN201780093285.XA patent/CN110997641A/zh active Pending
- 2017-12-21 US US16/631,737 patent/US11225465B2/en active Active
- 2017-12-21 JP JP2020502295A patent/JP7257697B2/ja active Active
- 2017-12-21 WO PCT/EP2017/084120 patent/WO2019015794A1/en not_active Ceased
- 2017-12-21 CA CA3070240A patent/CA3070240A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019034943A5 (https=) | ||
| CA2796967A1 (en) | Heterocyclic derivatives as alk inhibitors | |
| JP2012528847A5 (https=) | ||
| JP2009519965A5 (https=) | ||
| JP2007513969A5 (https=) | ||
| RU2008110949A (ru) | Соединения и композиции-иммуносупрессанты | |
| NZ609955A (en) | Sgc stimulators | |
| JP2007524696A5 (https=) | ||
| JP2013539791A5 (https=) | ||
| RU2003112610A (ru) | Производные пиразола для лечения вирксных заболеваний | |
| RU2011105151A (ru) | Азольные соединения | |
| JP2019537594A5 (https=) | ||
| JP2016537358A5 (https=) | ||
| JP2015531769A5 (https=) | ||
| RU2394028C2 (ru) | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы | |
| RU2009117705A (ru) | Производные 2-аминокарбонилпиридина | |
| JP2019512485A5 (https=) | ||
| JP2020527149A5 (https=) | ||
| JP2010513322A5 (https=) | ||
| JP2019537603A5 (https=) | ||
| JPWO2019148044A5 (https=) | ||
| ES2533095T3 (es) | Agonistas de receptores de esfingosina-1-fosfato | |
| JP2013542267A5 (https=) | ||
| JP2006507247A5 (https=) | ||
| JPWO2019144041A5 (https=) |